Market Access Blogs
What We’re Watching for 2024 – Top Trends in Market Access
Learn the top trends in market access to watch for in 2024 and how they'll impact your brand's strategy and success in the dynamic pharma landscape.
Why Market Access Matters to Marketers More Than Ever
Payer marketing, reimbursement strategy, payer engagement, market access – whatever term your organization might use, optimizing your brand value and communicating that value to your stakeholders is a vital discipline. Learn why.
Using Omnichannel to Tackle the Healthcare Giants
The consolidation of payers' subsidiaries is causing communication and market access challenges. Learn how omnichannel can help!
Five Key Ingredients to a Successful Market Access Strategy
Market access strategy and execution are critical to a drug's success or failure. Here are five key ingredients to ensure a successful market access strategy.
Checking in with Patrick Beers
“Boomerangs” are employees who leave and then return, and there are a variety of reasons to bring someone back. Find out what made Patrick Beers, Senior Vice President, Market Access, venture back to EVERSANA INTOUCH and what he's most excited about in this next chapter!
Meet Intouch Market Access – Our Latest Full-Service Affiliate
Gaining access to the medications they need has long been an obstacle for patients. Find out more about how Intouch Market Access can help brands create life-changing opportunities for those who need them.
Trans Healthcare: How Pharma Marketers Can Positively Impact This Underserved Community
In this POV, you’ll learn about the hurdles transgender people face in seeking care, and how pharma marketers can help clear the path.
Drug Pricing Reform: Never Out of the Headlines
Drug pricing is not going to disappear from legislators’ desks, and even big-business-friendly politicians have pharma in their sights. Learn more about what pharma marketers need to know and do in this climate.
$ to Switch: What Brands Need to Know and Do About New PBM Tactics
If Cigna's cash incentive becomes precedent, are you prepared to quickly react if your brand is the focus for a new non-medical switching campaign?
Drug Pricing Reform: Who Will Hold the Medicare Part D Contracting Cards?
Now is the time to scenario-plan for a world where drug pricing assumptions account for increased discounts. Find out what pharma needs to do to prepare for this evolution.